Home >> Life Sciences >> Healthcare

Nanobiotechnology Market for Drug Discovery, Drug Delivery, Diagnostics and Others: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Published: Apr-2016 | Format: PDF | Zion | Number of pages: 110 | Code: MRS - 55960


The report covers forecast and analysis for the nanobiotechnology market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the nanobiotechnology market along with the impact they have on the demand over the forecast period.Additionally, the report includes the study of opportunities available in the nanobiotechnology market on a global level.

In order to give the applications of this report a comprehensive view on the nanobiotechnology. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the nanobiotechnology market has also been included. The study encompasses a market attractiveness analysis, wherein service segments and application segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the nanobiotechnology market by segmenting the market based on services, applications and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Key application of nanobiotechnology market covered under this study includes discovery, drug delivery, diagnostics and other. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. This segmentation includes demand for nanobiotechnology based on individual applications in all the regions and countries.

The report also includes detailed profiles of end players such as Calando Pharmaceuticals Inc., Advanced Sensor Technologies, Affymetrix, Gilead Sciences, Applied Nanotech, Advectus Life Sciences, and Elan Pharmaceuticals and others. The detailed description of players includes parameters such as company overview, financial overview, business and recent developments of the company.

This report segments the global nanobiotechnology market as follows:

Global Nanobiotechnology market: Application Segment Analysis

  • Drug Discovery
  • Drug Delivery
  • Diagnostics
  • Others

Global Nanobiotechnology market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global nanobiotechnology market, 2015 – 2021 (USD Million)
    • 2.2. Global nanobiotechnology market : Snapshot
  • Chapter 3. Nanobiotechnology– Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global nanobiotechnology market drivers: Impact analysis
      • 3.2.2. Emerging Technology
    • 3.3. Market restraints
      • 3.3.1. Global nanobiotechnology market restraints: Impact analysis
      • 3.3.2. High cost
    • 3.4. Opportunities
      • 3.4.1. Growing demand pharmaceutical market
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by application segment
      • 3.6.2. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Nanobiotechnology Market – Competitive Landscape
    • 4.1. Company market share, 2015 (Subject To Data Availability)
  • Chapter 5. Global Nanobiotechnology Market – Application Segment Analysis
    • 5.1. Global nanobiotechnology market: Application overview
      • 5.1.1. Global nanobiotechnology market revenue share, by application, 2015 – 2021
    • 5.2. Drug Discovery
      • 5.2.1. Global nanobiotechnology market for drug discovery, 2015 – 2021 (USD Million)
    • 5.3. Drug Delivery
      • 5.3.1. Global nanobiotechnology market for drug delivery, 2015 – 2021 (USD Million)
    • 5.4. Diagnostics
      • 5.4.1. Global nanobiotechnology market for diagnostics, 2015 - 2021 (USD Million)
    • 5.5. Others
      • 5.5.1. Global nanobiotechnology market for other application, 2015 – 2021 (USD Million)
  • Chapter 6. Global Nanobiotechnology Market – Regional Segment Analysis
    • 6.1. Global nanobiotechnology market: Regional overview
      • 6.1.1. Global nanobiotechnology market revenue share, by region, 2015 – 2021
    • 6.2. North America
      • 6.2.1. North America nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
      • 6.2.2. U.S.
        • 6.2.2.1. U.S. nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany nanobiotechnology market revenue, by application, 2015 – 2021 , (USD Million)
      • 6.3.3. France
        • 6.3.3.1. France nanobiotechnology market revenue, by application, 2015 – 2021 , (USD Million)
      • 6.3.4. UK
        • 6.3.4.1. UK nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific nanobiotechnology market revenue, by application, 2015 – 2021 , (USD Million)
      • 6.4.2. China
        • 6.4.2.1. China nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
      • 6.4.4. India
        • 6.4.4.1. India nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
    • 6.6. Middle East and Africa
      • 6.6.1. Middle East and Africa nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
  • Chapter 7. Company Profile
    • 7.1. Calando Pharmaceuticals Inc
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. Advanced Sensor Technologies
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Gilead Sciences
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Applied Nanotech
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Advectus Life Sciences
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Elan Pharmaceuticals
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. Affymetrix
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments

List of Tables

1. Nanobiotechnology market: Market snapshot   
2. Drivers of global nanobiotechnology market: Impact analysis
3. Restraints of global nanobiotechnology market: Impact analysis  
4. North America nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
5. U.S. nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
6. Germany nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
7. France nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
8. UK nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
9. Asia Pacific nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
10. China nanobiotechnology market revenue, by application 2015 – 2021 (USD Million)
11. Japan nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
12. India nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
13. Latin America nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
14. Brazil nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)
15. Middle East and Africa nanobiotechnology market revenue, by application, 2015 – 2021 (USD Million)


List of Figures

1. Market research process
2. Market research methodology
3. Global nanobiotechnology market revenue, 2015 – 2021 (USD Million)
4. Porter’s five forces analysis
5. Nanobiotechnology: Market attractiveness analysis, by application segment
6. Nanobiotechnology: Market attractiveness analysis, by regional segment
7. Company market share analysis, 2015 – 2021
8. Global nanobiotechnology market revenue share by application, 2015 – 2021
9. Global  nanobiotechnology market for drug discovery, 2015 – 2021 , (USD Million)
10. Global  nanobiotechnology market for drug delivery, 2015 – 2021 , (USD Million)
11. Global nanobiotechnology market for  diagnostics, 2015 – 2021 (USD Million)
12. Global nanobiotechnology market for other applications, 2015 – 2021 , (USD Million)

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Zion Research uses the synergy of combination of both primary research and secondary research for its research reports. For this study, we have conducted extensive primary research, wherein we have conducted in-depth interviews of the key opinion leader of this industry. Primary research make up for the biggest chunk of our data sources in addition to secondary research.

We referred to product literature of leading industry participants, annual reports, press releases, government publications, and other relevant sources for data collection and analysis thereof. Secondary research also includes a search of recent trade journals, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.

Zion Research has collected key data related to the Nanobiotechnology Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso, and macroeconomic indicators of the market.

This report is based on in-depth qualitative and quantitative analyses of the Global Nanobiotechnology Market. The quantitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically partake in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Based on the research results and technical insights thus gathered, Zion research analysts have provided a comprehensive analysis of the varied aspects of the market. The impact of global economic conditions and other macroeconomic indicators was also considered when assessing the market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Nanobiotechnology is an integration of physical sciences, molecular engineering and biology that plays a vital role in pharmaceuticals and health care. It provides new class of multifunctional systems and devices for biological analysis with better sensitivity and specificity. Key techniques in nanobiotechnology include 3D imaging in live cells, real-time imaging, and single molecule imaging bioanalytical microarrays and microfluidic devices and biosensors.  Nanobiotechnology is used in nanomolecular diagnostics and it extends the limits of molecular diagnostics to the nanoscale.

The global nanobiotechnology market is expected to witness significant growth over the forecast period. The global nanobiotechnology market is mainly driven by increasing health awareness among the people and advancement in technology. Government support has provided strong boost to nanobiotechnology market in North America and Asia Pacific in the past few years. Concept of advancement in technology to provide better health services expected to fuel the nanobiotechnology market over the forecast period. However, environmental regulation regarding disposable waste expected to hamper the growth of nanobiotechnology market. Lack of resources and high technological cost may pose a challenge for nanobiotechnology market during the forecast period. Furthermore, increasing demand from medical and pharmaceutical industry is expected to open up new growth avenues in the years to come.

Global Nano biotechnology Market

The nanobiotechnology market is segmented on the basis of different application such as drug discovery, drug delivery, diagnostics and others. The diagnostics segment dominated the market with largest share of the total market in 2015. This growth can be attributed to technological advancement in medical sector to provide better health services. Drug delivery also accounted for significant share and expected to witness strong growth in the years to come. Drug discovery and other application segment are expected to exhibit significant growth during the forecast period.

North America dominated the nanobiotechnology market and accounted for the significant share of the global market in 2015. In terms of revenue, North America was followed by Asia Pacific region. In terms of revenue, Asia Pacific was the second largest market for nanobiotechnology. The telemedicine market in Asia Pacific region is expected to exhibit strong growth owing to rising government support and rapid growth in population. Europe, Latin America and Middle East & Africa are also expected to experience significant growth of nanobiotechnology market in the years to come.

Some of the leading players includes in nanobiotechnology market such as Calando Pharmaceuticals Inc., Advanced Sensor Technologies, Affymetrix, Gilead Sciences, Applied Nanotech, Advectus Life Sciences, and Elan Pharmaceuticals and others.

  • Payment Mode
Single User | $(USD)4199 View Pricing